Nimotuzumab in pediatric glioma

Phase I single-dose study of intracavitary-administered Nimotuzumab labeled with 188-Re in adult recurrent high-grade glioma

(2010) Angel Casaco et al.   CANCER BIOLOGY & THERAPY

Phase I and Pharmacokinetic Studies of Erlotinib Administered Concurrently with Radiotherapy for Children, Adolescents, and Young Adults with High-Grade Glioma

(2009) A. Broniscer et al.   CLINICAL CANCER RESEARCH

Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034

(2009) Martin J. van den Bent et al.   JOURNAL OF CLINICAL ONCOLOGY

Biodistribution and internal dosimetry of the 188Re-labelled humanized monoclonal antibody anti-epidemal growth factor receptor, nimotuzumab, in the locoregional treatment of malignant gliomas

(2009) Leonel A. Torres et al.   NUCLEAR MEDICINE COMMUNICATIONS

Enhancement of the antitumor activity of ionising radiation by nimotuzumab, a humanised monoclonal antibody to the epidermal growth factor receptor, in non-small cell lung cancer cell lines of differing epidermal growth factor receptor status

(2008) Y Akashi et al.   BRITISH JOURNAL OF CANCER

Epidermal Growth Factor Receptor Inhibitors in Neuro-oncology: Hopes and Disappointments

(2008) A. A. Brandes et al.   CLINICAL CANCER RESEARCH

Protein Expression of Platelet-Derived Growth Factor Receptor Correlates with Malignant Histology and PTEN with Survival in Childhood Gliomas

(2008) H. K. Thorarinsdottir et al.   CLINICAL CANCER RESEARCH

Targeting the Epidermal Growth Factor Receptor in High-Grade Astrocytomas

(2008) Will R. Voelzke et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

Inconsistent Criteria Used in American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer

(2008) Fatima Cardoso et al.   JOURNAL OF CLINICAL ONCOLOGY

Pediatric Phase I and Pharmacokinetic Study of Erlotinib Followed by the Combination of Erlotinib and Temozolomide: A Children's Oncology Group Phase I Consortium Study

(2008) Regina I. Jakacki et al.   JOURNAL OF CLINICAL ONCOLOGY

Detection of humoral response in patients with glioblastoma receiving EGFRvIII-KLH vaccines

(2008) Robert J. Schmittling et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Epithelial Growth Factor Receptor inhibitors for treatment of recurrent or progressive high grade glioma: an exploratory study

(2008) M. Preusser et al.   JOURNAL OF NEURO-ONCOLOGY

Tyrosine kinase expression in pediatric high grade astrocytoma

(2008) Muh-Lii Liang et al.   JOURNAL OF NEURO-ONCOLOGY

Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma

(2008) Daphne A. Haas-Kogan et al.   NEURO-ONCOLOGY

Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma

(2008) John H. Sampson et al.   SEMINARS IN IMMUNOLOGY

Current situation of Panitumumab, Matuzumab, Nimotuzumab and Zalutumumab

(2007) Fernando Rivera et al.   ACTA ONCOLOGICA